EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multicomponent Lipid Nanoparticles for RNA Transfection

Nataliya Gretskaya, Mikhail Akimov iD, Dmitry Andreev, Anton Zalygin iD, Ekaterina Belitskaya, Galina Zinchenko, Elena Fomina-Ageeva, Ilya Mikhalyov, Elena Vodovozova iD, Vladimir Bezuglov iD

Pharmaceutics · 20.04.2023 · 15 (4) · 1289

DOI: 10.3390/pharmaceutics15041289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 20.04.2023. Verfasst von Nataliya Gretskaya und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and High Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the wide variety of available cationic lipid platforms for the delivery of nucleic acids into cells, the optimization of their composition has not lost its relevance. The purpose of this work was to develop multi-component cationic lipid nanoparticles (LNPs) with or without a hydrophobic core from natural lipids in order to evaluate the efficiency of LNPs with the widely used cationic lipoid DOTAP (1,2-dioleoyloxy-3-[trimethylammonium]-propane) and the previously unstudied oleoylcholine (Ol-Ch), as well as the ability of LNPs containing GM3 gangliosides to transfect cells with mRNA and siRNA. LNPs containing cationic lipids, phospholipids and cholesterol, and surfactants were prepared according to a three-stage procedure. The average size of the resulting LNPs was 176 nm (PDI 0.18). LNPs with DOTAP mesylate were more effective than those with Ol-Ch. Core LNPs demonstrated low transfection activity compared with bilayer LNPs. The type of phospholipid in LNPs was significant for the transfection of MDA-MB-231 and SW 620 cancer cells but not HEK 293T cells. LNPs with GM3 gangliosides were the most efficient for the delivery of mRNA to MDA-MB-231 cells and siRNA to SW620 cells. Thus, we developed a new lipid platform for the efficient delivery of RNA of various sizes to mammalian cells.

Schlagwörter

Stichwörter der Autor:innen

GM3 gangliosidecationic lipidslipid nanoparticlesmRNA transfectionsiRNA transfection

Autor:innen und Institutionen

  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.
  • Department of Translational Medicine, National Research Nuclear University, Moscow Engineering Physics Institute, Moscow 115409, Russia.

ORCID-Profile: Mikhail Akimov, Anton Zalygin, Elena Vodovozova, Vladimir Bezuglov

Förderung

  • Ministry of Science and High Education of the Russian Federation

Zitieren

APA

Gretskaya, N., Akimov, M., Andreev, D., Zalygin, A., Belitskaya, E., Zinchenko, G., Fomina-Ageeva, E., Mikhalyov, I., Vodovozova, E., & Bezuglov, V. (2023). Multicomponent Lipid Nanoparticles for RNA Transfection. Pharmaceutics, 15(4), 1289. https://doi.org/10.3390/pharmaceutics15041289

Vancouver

Gretskaya N, Akimov M, Andreev D, Zalygin A, Belitskaya E, Zinchenko G, et al. Multicomponent Lipid Nanoparticles for RNA Transfection. Pharmaceutics. 2023;15(4):1289. doi:10.3390/pharmaceutics15041289

BibTeX
@article{Gretskaya2023,
  author = {Gretskaya, Nataliya and Akimov, Mikhail and Andreev, Dmitry and Zalygin, Anton and Belitskaya, Ekaterina and Zinchenko, Galina and Fomina-Ageeva, Elena and Mikhalyov, Ilya and Vodovozova, Elena and Bezuglov, Vladimir},
  title = {Multicomponent Lipid Nanoparticles for RNA Transfection},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1289},
  doi = {10.3390/pharmaceutics15041289}
}
Kostenlos starten →